£520.00

The 2023-2028 Outlook for Enteric Disease Testing-Treatment in the United States

Price data last checked 89 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 2 days • 2 data points (No recent data available)

Historical
Generating forecast...
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 January 2026 26 January 2026 26 January 2026 26 January 2026 27 January 2026

Price Distribution

Price distribution over 2 days • 1 price levels

Days at Price
2 days 0 1 1 2 2 £520 Days at Price

Price Analysis

Most common price: £520 (2 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 2 days

Product Specifications
Format
paperback
ASIN
B0BLR57B6X
Category
Books > Subjects
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 World Outlook for Enteric Disease Testing-Treatment
99% match

The 2023-2028 World Outlook for Enteric Disease Testing-Treatment

£795.00 31 Jan 2026
The 2023-2028 Outlook for Enteric Disease Testing-Treatment in India
98% match

The 2023-2028 Outlook for Enteric Disease Testing-Treatment in India

£515.00 10 Dec 2025
The 2023-2028 Outlook for E. Coli Testing in the United States
97% match

The 2023-2028 Outlook for E. Coli Testing in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Tropical Disease Testing Products in the United States
97% match

The 2023-2028 Outlook for Tropical Disease Testing Products in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
97% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Bloodstream Infection Testing in the United States
97% match

The 2023-2028 Outlook for Bloodstream Infection Testing in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in the United States
97% match

The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Traveler's Diarrhea Therapeutics in the United States
97% match

The 2023-2028 Outlook for Traveler's Diarrhea Therapeutics in the United States

£520.00 26 Jan 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
97% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States

£520.00 03 Feb 2026
The 2023-2028 Outlook for Ulcerative Proctitis in the United States
97% match

The 2023-2028 Outlook for Ulcerative Proctitis in the United States

£520.00 04 Mar 2026
The 2023-2028 Outlook for Atopic Dermatitis Treatments in the United States
97% match

The 2023-2028 Outlook for Atopic Dermatitis Treatments in the United States

£520.00 23 Jan 2026
The 2023-2028 Outlook for Amyloidosis Treatments in the United States
96% match

The 2023-2028 Outlook for Amyloidosis Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
96% match

The 2023-2028 Outlook for Sarcopenia Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Traveler's Diarrhea Treatments in the United States
96% match

The 2023-2028 Outlook for Traveler's Diarrhea Treatments in the United States

£520.00 26 Jan 2026
The 2023-2028 Outlook for Enzyme Replacement Therapy for Gaucher Diseases in the United States
96% match

The 2023-2028 Outlook for Enzyme Replacement Therapy for Gaucher Diseases in the United States

£520.00 18 Feb 2026
The 2023-2028 Outlook for At-Home Drug of Abuse Testing in the United States
96% match

The 2023-2028 Outlook for At-Home Drug of Abuse Testing in the United States

£520.00 17 Feb 2026
The 2023-2028 Outlook for Diabetes Treatments in the United States
96% match

The 2023-2028 Outlook for Diabetes Treatments in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for HIV-AIDS Testing in the United States
96% match

The 2023-2028 Outlook for HIV-AIDS Testing in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Diabetic Ulcer Treatments in the United States
96% match

The 2023-2028 Outlook for Diabetic Ulcer Treatments in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States
96% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Endoscopes (Requiring Endoscopy Procedures) in the United States
96% match

The 2023-2028 Outlook for Endoscopes (Requiring Endoscopy Procedures) in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States
96% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Motion Sickness Treatments in the United States
96% match

The 2023-2028 Outlook for Motion Sickness Treatments in the United States

£520.00 31 Jan 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States
96% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States

£520.00 28 Jan 2026